AD113
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AD113, covering 2023-08-21 to 2023-08-21. Get the full timeline:
Most recent: Clinical Trial Update: Trial of AD113 and Atomoxetine in OSA Patients With Hypertension [Phase 2]